Holmium Laser Enucleation of the prostate (HoLEP) and its effect on the sexual /erectile function - a prospective trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00030357

Enrollment

200

Registered

2023-02-13

Start date

2021-01-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N40 F52

Interventions

Group 1: observational trial patients receiving a HoLEP will be asked about their sexual function and quality of life pre surgery and after 3,6,12 months post surgery via standardized questionnaires.

Eligibility

Sex/Gender

Male

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: obstructive voiding disorder

Exclusion criteria

Exclusion criteria: patients unable to consent

Design outcomes

Primary

Measure	Time frame
the sexual / erectile function and its course after HoLEP therapy is evaluated using questionnaires before surgery, 3 months after surgery, 6 months after surgery and 12 months after therapy	—

Secondary

Measure	Time frame
an enlarged prostate (preoperative condition) has a negative impact on the patient's sexual / erectile function (also evaluated by questionnaires preoperatively, 3 months post-operatively, 6 months post-operatively and 12 months post-operatively.	—

Countries

Germany

Contacts

Public ContactSascha Ahyai

Universitätsmedizin Göttingen

sascha.ahyai@med.uni-goettingen.de0049 551 39 68160

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026